Abstract
Is topical testosterone less likely to cause polycythemia than IM testosterone in patients on testosterone replacement therapy?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Evidence-based practice : patient-oriented evidence that matters
Paper Title
Journal
Date
